CN Patent

CN105229012B — 用于治疗细菌感染的化合物和方法

Assigned to AstraZeneca AB · Expires 2017-07-18 · 9y expired

What this patent protects

本文公开了式(I)的化合物、其药学上可接受的盐以及式(I)的化合物用于治疗细菌感染的用途。

USPTO Abstract

本文公开了式(I)的化合物、其药学上可接受的盐以及式(I)的化合物用于治疗细菌感染的用途。

Drugs covered by this patent

zoliflodacin (ZOLIFLODACIN)

Patent Metadata

Patent number: CN105229012B
Jurisdiction: CN
Classification: —
Expires: 2017-07-18
Drug substance claim: No
Drug product claim: No
Assignee: AstraZeneca AB
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.